Illumina, Inc. (LON:0J8Z)
London · Delayed Price · Currency is GBP · Price in USD 113.63
-3.33 (-2.84%)
Feb 12, 2026, 5:00 PM GMT
Illumina Market Cap
Illumina has a market cap or net worth of 13.03 billion as of February 12, 2026. Its market cap has decreased by -23.51% in one year.
Market Cap
13.03B
Enterprise Value
13.65B
Revenue
3.22B
Ranking
n/a
PE Ratio
20.68
Stock Price
113.63
Market Cap Chart
Since July 28, 2000, Illumina's market cap has increased from 174.80M to 13.03B, an increase of 7,356.12%. That is a compound annual growth rate of 18.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 13.03B | -12.47% |
| Dec 31, 2025 | 14.89B | -12.04% |
| Dec 31, 2024 | 16.93B | -2.48% |
| Dec 29, 2023 | 17.36B | -34.24% |
| Dec 30, 2022 | 26.40B | -39.89% |
| Dec 31, 2021 | 43.92B | 10.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.41B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |